Adalta Share Price and Company Fundamentals
Last traded: Last Tuesday at 11:59 PM
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is based in Bundoora, Australia.
|Primary activities||Drug discovery and development|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||2 Park Drive Unit 15 Bundoora VIC 3083 Australia|
|Phone / Fax||61 3 9479 5159 / 61 2 8583 3040|
|Share registry||AUTOMIC REGISTRY SERVICES|
Adalta paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.1AD dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
1AD's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Aug 2022, following are the company executives and directors listed on Adalta.
|Dr. Timothy Charles Oldham B.Sc., BSc(Hons), L.L.B., LLB(Hons), Ph.D.||CEO, MD & Director||351.44k|
|Dr. Dallas Hartman||Chief Operating Officer|
|Mr. Cameron Jones C.A.||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Adalta is and its enterprise value is .
The 1AD's stocks Beta value is 0.76 making it 24% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Adalta (1AD)
Adalta (ASX:1AD) Frequently Asked Questions
1. What is Adalta's Stock Symbol?
Adalta trades on ASX under the ticker symbol "1AD".
2. What is Adalta's stock price today?
One share of 1AD stock can currently be purchased for approximately $0.05.
3. How can I contact Adalta?
Adalta's mailing address is 2 Park Drive Unit 15 Bundoora VIC 3083 Australia. The company can be reached via phone at 61 3 9479 5159.
4. What is Adalta's official website?
The official website of Adalta is https://www.adalta.com.au.
5. Which share registry manages Adalta's stock?
Adalta's stock is managed by AUTOMIC REGISTRY SERVICES.